 |
|
|
 |
|
Vaginal Microbicides Might Help More Men Than Women
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 "Since monthly testing will take place in the dapivirine trial, we predict that few, if any, cases of acquired resistance will arise during the trial, even if the drug is readily absorbed (i.e., the microbicide is high risk)," the researchers wrote. "Therefore, our analyses have shown that high-risk microbicides could pass Phase III trials, as their potential to cause resistance will be masked by frequent testing."
More information
Text Continues Below

The U.S. Department of Health & Human Services has more about HIV prevention drugs.
Page: << Prev | 1 | 2
-- Kevin McKeever
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 7/10/2008
|
 |

SOURCE: University of California, Los Angeles, news release, July 7, 2008
|